Fact CheckerSign in

NCT06140316Completed

Biopsychosocial and Motor Predictor of Functional Recovery in Stroke Survivors

Biopsychosocial and Motor Predictor of Functional Recovery in Stroke Survivors, A Prospective Cohort

Source: ClinicalTrials.gov · Last updated 7 May 2024

Brief summary (registry, in English)

Up to the researcher knowledge, there is currently limited literature available that thoroughly investigates the biopsychosocial and motor predictors of functional recovery in stroke survivors. Previous studies have only focused on examining these factors individually, without considering their collective impact on functional outcomes. As a result, there is a significant research gap in understanding how these factors interact and influence the recovery process. By integrating the biopsychosocial model with motor predictors, this study will provide a unique and comprehensive perspective on the recovery trajectory of stroke survivors.

Status (registry)
Completed
Study type
Observational
Enrollment
104 (actual)
First submitted
15 Nov 2023
Start date
15 Nov 2023
Primary completion date
10 Apr 2024
Lead sponsor
Riphah International University
Diseases
Stroke
NCT number
NCT06140316

What you commit to

  • Study type: Observational
  • Participants enrolled: 104
  • From 15 Nov 2023 to the primary completion date, 10 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with previous stroke history

Other illness

  • Presence or history of intracranial tumor, with/without tumor bleeding.
  • Presence or history of traumatic brain injury.
  • Presence or history of encephalopathy/myelopathy.
  • Presence or history of central nervous system infection/ inflammation.
  • Presence or history of degenerative central or peripheral nervous system disease, including neuropathy, neuronopathy, or myopathy

Who the study is looking for

  • Either gender
  • Patients with age between 45 to 65 years.
  • Ischemic stroke patients
  • Patients having stroke from 3 to 7 days at the time of recruitment

Age in the registry: 45 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
DHQ Dera Ghazi Khan
Coordinator of this site? Confirm its status
Dera Ghazi KhanPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.